cell titer-glo assay (Promega)
90
Structured Review
Promega
cell titer-glo assay
Cell Titer Glo Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell-titer+glo/celltiter+glo+luminescent+cell+viability+assay/pmc10193989__pnas__2219755120__sapp-48-4-7
Average 90 stars, based on 1 article reviews
Cell Titer Glo Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell-titer+glo/celltiter+glo+luminescent+cell+viability+assay/pmc10193989__pnas__2219755120__sapp-48-4-7
Average 90 stars, based on 1 article reviews
cell titer-glo assay - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Luciferase:Article Title: Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer Article Snippet: Sphere cell viability was evaluated by Article Title: Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma. Article Snippet: AlamarBlue reagent (Thermo Scientific) or Article Title: Zika virus strains for treatment of glioma Article Snippet: Proliferation and Sphere Formation Assay Cell viability was measured using Article Title: KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Article Snippet: Gastric adenocarcinoma (GAC) remains a significant global health challenge, with over a million new cases annually.. Peritoneal carcinomatosis (PC), detected in ~20 % of cases at diagnosis and ~45 % later, is uniformly fatal, with limited treatment options.. This study investigated the role of KAP1 in GAC progression, focusing on its interaction with YAP1 and cancer stemness traits. Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: For KASUMI-1 experiments, cells were grown in 96-well plates and similarly incubated with compounds at indicated concentrations for 72h in Article Title: Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models Article Snippet: At day five, cell viability was measured using Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: In brief, the effects of compounds on Article Title: Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia Article Snippet: After 24 hours, cells were treated with DMSO or TTFA (200μM) for 30 minutes in triplicate, before viability was impacted, and assayed using Activity Assay:Article Title: Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer Article Snippet: Sphere cell viability was evaluated by Article Title: Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma. Article Snippet: AlamarBlue reagent (Thermo Scientific) or Article Title: Zika virus strains for treatment of glioma Article Snippet: Proliferation and Sphere Formation Assay Cell viability was measured using Article Title: KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Article Snippet: Gastric adenocarcinoma (GAC) remains a significant global health challenge, with over a million new cases annually.. Peritoneal carcinomatosis (PC), detected in ~20 % of cases at diagnosis and ~45 % later, is uniformly fatal, with limited treatment options.. This study investigated the role of KAP1 in GAC progression, focusing on its interaction with YAP1 and cancer stemness traits. Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: For KASUMI-1 experiments, cells were grown in 96-well plates and similarly incubated with compounds at indicated concentrations for 72h in Article Title: Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models Article Snippet: At day five, cell viability was measured using Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: In brief, the effects of compounds on Article Title: Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia Article Snippet: After 24 hours, cells were treated with DMSO or TTFA (200μM) for 30 minutes in triplicate, before viability was impacted, and assayed using CellTox Assay:Article Title: Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer Article Snippet: Sphere cell viability was evaluated by Article Title: Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma. Article Snippet: AlamarBlue reagent (Thermo Scientific) or Article Title: Zika virus strains for treatment of glioma Article Snippet: Proliferation and Sphere Formation Assay Cell viability was measured using Article Title: KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Article Snippet: Gastric adenocarcinoma (GAC) remains a significant global health challenge, with over a million new cases annually.. Peritoneal carcinomatosis (PC), detected in ~20 % of cases at diagnosis and ~45 % later, is uniformly fatal, with limited treatment options.. This study investigated the role of KAP1 in GAC progression, focusing on its interaction with YAP1 and cancer stemness traits. Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: For KASUMI-1 experiments, cells were grown in 96-well plates and similarly incubated with compounds at indicated concentrations for 72h in Article Title: Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models Article Snippet: At day five, cell viability was measured using Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: In brief, the effects of compounds on Article Title: Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia Article Snippet: After 24 hours, cells were treated with DMSO or TTFA (200μM) for 30 minutes in triplicate, before viability was impacted, and assayed using Incubation:Article Title: Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer Article Snippet: Sphere cell viability was evaluated by Article Title: Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma. Article Snippet: AlamarBlue reagent (Thermo Scientific) or Article Title: Zika virus strains for treatment of glioma Article Snippet: Proliferation and Sphere Formation Assay Cell viability was measured using Article Title: KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Article Snippet: Gastric adenocarcinoma (GAC) remains a significant global health challenge, with over a million new cases annually.. Peritoneal carcinomatosis (PC), detected in ~20 % of cases at diagnosis and ~45 % later, is uniformly fatal, with limited treatment options.. This study investigated the role of KAP1 in GAC progression, focusing on its interaction with YAP1 and cancer stemness traits. Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: For KASUMI-1 experiments, cells were grown in 96-well plates and similarly incubated with compounds at indicated concentrations for 72h in Article Title: Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models Article Snippet: At day five, cell viability was measured using Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: In brief, the effects of compounds on Article Title: Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia Article Snippet: After 24 hours, cells were treated with DMSO or TTFA (200μM) for 30 minutes in triplicate, before viability was impacted, and assayed using Lysis:Article Title: Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer Article Snippet: Sphere cell viability was evaluated by Article Title: Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma. Article Snippet: AlamarBlue reagent (Thermo Scientific) or Article Title: Zika virus strains for treatment of glioma Article Snippet: Proliferation and Sphere Formation Assay Cell viability was measured using Article Title: KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Article Snippet: Gastric adenocarcinoma (GAC) remains a significant global health challenge, with over a million new cases annually.. Peritoneal carcinomatosis (PC), detected in ~20 % of cases at diagnosis and ~45 % later, is uniformly fatal, with limited treatment options.. This study investigated the role of KAP1 in GAC progression, focusing on its interaction with YAP1 and cancer stemness traits. Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: For KASUMI-1 experiments, cells were grown in 96-well plates and similarly incubated with compounds at indicated concentrations for 72h in Article Title: Oral estrogen receptor PROTAC® vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models Article Snippet: At day five, cell viability was measured using Article Title: Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. Article Snippet: In brief, the effects of compounds on Article Title: Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia Article Snippet: After 24 hours, cells were treated with DMSO or TTFA (200μM) for 30 minutes in triplicate, before viability was impacted, and assayed using |